SCHEMBL4989142

SCHEMBL4989142

CC(C)CNC(=O)C(N)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
PRMT5 O14744 4/20 0.49
WDR77 Q9BQA1 4/20 0.49
HPGD P15428 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.45
HSD17B10 Q99714 1/20 0.45
BCAT2 O15382 1/20 0.45
LARS1 Q9P2J5 1/20 0.44
POLB P06746 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
APAF1 O14727 1/20 0.44
GLS O94925 2/20 0.43
ANPEP P15144 1/20 0.43
CTRB1 P17538 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4222284 0.86 PRMT5 (0.51) PRMT5WDR77LMNABCAT2GLS
SCHEMBL996650 0.83 HPGD (0.50) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL4838617 0.82 PKM (0.57) KMT2AMEN1PRMT5WDR77BCAT2
SCHEMBL3746577 0.82 PKM (0.57) KMT2AMEN1PRMT5WDR77BCAT2
SCHEMBL15709156 0.82 CNR1 (0.59) KMT2AMEN1ALDH1A1MAPTPOLB
SCHEMBL7748966 0.82 ERCC1 (0.55) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL4243720 0.81 KMT2A (0.49) KMT2AMEN1ALDH1A1MAPTHPGD
Hydrochloric Acid SCHEMBL4196019 0.81 PKM (0.55) KMT2AMEN1PRMT5WDR77BCAT2
SCHEMBL13765364 0.81 NAAA (0.58) KMT2AMEN1ALDH1A1MAPTPRMT5
Hydrochloric Acid SCHEMBL28750033 0.81 PKM (0.55) KMT2AMEN1PRMT5WDR77BCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468378-B2 Substituted quinoline compounds PFIZER INC. (US) 2008-12-23 US disclosed
US-7393958-B2 Triamide-substituted heterobicyclic compounds PFIZER, INC. (US) 2008-07-01 US disclosed
US-7368573-B2 Triamide-substituted heterobicyclic compounds PFIZER INC. (US) 2008-05-06 US disclosed
US-20070093525-A1 Triamide-substituted heterobicyclic compounds PFIZER INC 2007-04-26 US disclosed
EP-1716137-A1 SUBSTITUTED QUINOLINE COMPOUNDS Pfizer Products Incorporated (US) 2006-11-02 EP disclosed
US-20060223851-A1 TRIAMIDE-SUBSTITUTED HETEROBICYCLIC COMPOUNDS BERTINATO PETER 2006-10-05 US disclosed
US-20050234099-A1 Substituted quinoline compounds PFIZER INC 2005-10-20 US disclosed
WO-2005080373-A1 SUBSTITUTED QUINOLINE COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234099-A1 Substituted quinoline compounds APOB, APOL1, MTPN KMT2A 3968/4885MEN1 1437/4885ALDH1A1 2807/4885
US-20060223851-A1 TRIAMIDE-SUBSTITUTED HETEROBICYCLIC COMPOUNDS APOB, MTPN, CTRB1 KMT2A 4384/4885MEN1 1637/4885ALDH1A1 3299/4885
US-20070093525-A1 Triamide-substituted heterobicyclic compounds APOB, MTPN, CTRB1 KMT2A 4384/4885MEN1 1637/4885ALDH1A1 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.